Stamler David Alleninsider trades

In SEC Form 4 filings, Stamler David Allen is listed as Chief Executive Officer of Alterity Therapeutics Ltd (ATHE). Stamler David Allen reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 8.

Companies and roles

Company	Role	Transactions	Last filed
ATHEAlterity Therapeutics Ltd	Chief Executive Officer	1	Sep 8

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-08

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
ATHEAlterity Therapeutics Ltd	Aug 31	Sep 8	P · derivative	47,620	$0.50	Purchase +$23,810	not reported	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.